Cargando…
Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program
Remimazolam, an ultra-short-acting benzodiazepine sedative, was first approved in 2020 in Japan as a general anesthetic for adults. However, its utilization in pediatric settings remains unexplored and, to date, is confined to isolated case reports due to a lack of specific pediatric labeling. The p...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532234/ https://www.ncbi.nlm.nih.gov/pubmed/37762878 http://dx.doi.org/10.3390/jcm12185937 |